ArticleFrontiers in pharmacology2024

Pharmacological targets of SGLT2 inhibition on prostate cancer mediated by circulating metabolites: a drug-target Mendelian randomization study.

Yilong Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.